Rabbit TRAF6 Polyclonal Antibody | anti-TRAF6 antibody

TRAF6 Antibody

Cat. Num. AAA840197

• Reactivity: Human, Mouse, Rat
• Applications: Western Blot
• Purity: Affinity purified
• Synonyms: TRAF6; Polyclonal Antibody; TRAF6 Antibody; RNF85; MGC:3310; anti-TRAF6 antibody

• Host: Rabbit
• Reactivity: Human, Mouse, Rat
• Clonality: Polyclonal
• Isotype: IgG
• Purity/Purification: Affinity purified
• Form/Format: 100 ug (0.5 mg/ml) affinity purified rabbit polyclonal antibody in phosphate-buffered saline (PBS) containing 30% glycerol, 0.5% BSA, and 0.01% thimerosal.; Appearance: Colorless liquid
• Concentration: 0.5 mg/ml (varies by lot)
• Sequence Length: 530

• Applicable Applications for anti-TRAF6 antibody: Western Blot (WB)
• Application Notes: Western blotting (0.5-4 ug/ml). However, the optimal concentrations should be determined individually. The antibody recognizes 54 kDa TRAF6 in samples of human and mouse origins. Reactivity to other species has not been tested.
• Immunogen: Synthetic peptide surrounding amino acid 436 of rat TRAF6
• Handling: The antibody solution should be gently mixed before use.
• Preparation and Storage: At -20 degree C; Shelf Life: 12 months

Testing Data

Related Product Information for anti-TRAF6 antibody

Background: TRAFs (TNF receptor associated proteins) form a family of cytoplasmic adapter proteins that mediate signal transduction from many members of the TNF-receptor superfamily and the interleukin-1 receptor. The carboxy-terminal region of TRAFs is required for self-association and interaction with receptor cytoplasmic domains following ligand-induced oligomerization. Recent molecular cloning studies have lead to identification of six TRAFs (TRAF1-TRAF6). Recently it has been shown that TRANCE/OPGL activates the antiapoptotic serine/threonine kinase Akt/PKB thromugh a signaling complex involving c-Src and TRAF6. Mice deficient in TRAF6 are osteopetrotic with defects in bone remodeling and tooth eruption due to impaired osteoclast function. Like TRAF2 and TRAF3, TRAF6 is also essential for perinatal and postnatal survival. These findings establish diverse and critical roles for TRAF6 in perinatal and postnatal survival, bone metabolism, LPS, and cytokine signaling.

NCBI and Uniprot Product Information

• NCBI GI #: 157820501
• NCBI GeneID: 311245
• NCBI Accession #: NP_001101224
• NCBI GenBank Nucleotide #: NM_001107754.2
• Molecular Weight: 60,253 Da
• NCBI Official Full Name: TNF receptor-associated factor 6
• NCBI Official Synonym Full Names: TNF receptor-associated factor 6, E3 ubiquitin protein ligase
• NCBI Official Symbol: Traf6
• NCBI Protein Information: TNF receptor-associated factor 6
• UniProt Protein Name: TNF receptor-associated factor 6
• Protein Family: TNF receptor-associated factor
• UniProt Gene Name: Traf6
• UniProt Entry Name: TRAF6_RAT

Uniprot Description

TRAF6: E3 ubiquitin ligase that, together with UBE2N and UBE2V1, mediates the synthesis of 'Lys-63'-linked-polyubiquitin chains conjugated to proteins, such as IKBKG, AKT1 and AKT2. Also mediates ubiquitination of free/unanchored polyubiquitin chain that leads to MAP3K7 activation. Leads to the activation of NF- kappa-B and JUN. May be essential for the formation of functional osteoclasts. Seems to also play a role in dendritic cells (DCs) maturation and/or activation. Represses c-Myb-mediated transactivation, in B-lymphocytes. Adapter protein that seems to play a role in signal transduction initiated via TNF receptor, IL- 1 receptor and IL-17 receptor. Regulates osteoclast differentiation by mediating the activation of adapter protein complex 1 (AP-1) and NF-kappa-B, in response to RANK-L stimulation. Homotrimer. Homooligomer. N-terminal region is dimeric while C-terminal region is trimeric; maybe providing a mode of oligomerization. Binds to TNFRSF5/CD40 and TNFRSF11A/RANK. Associates with NGFR, TNFRSF17, IRAK1, IRAK2, IRAK3, IRAK4, RIPK2, MAP3K1, MAP3K5, MAP3K14, CSK, TRAF, TRAF-interacting protein TRIP and TNF receptor associated protein TDP2. Interacts with IL17R. Interacts with SQSTM1 bridging NTRK1 and NGFR. Forms a ternary complex with SQSTM1 and PRKCZ. Interacts with PELI1, PELI2 and PELI3. Binds UBE2V1. Interacts with MAVS/IPS1. Interacts with TAX1BP1. Interacts with IL1RL1. Interacts with TRAFD1. Interacts with ZNF675. Interacts with AJUBA. Interacts with TICAM1 and TICAM2. Interacts with ZFAND5. Interacts with ARRB1 and ARRB2. Interacts with MAP3K7 and TAB1/MAP3K7IP1; during IL-1 signaling. Interacts with UBE2N. Interacts with TGFBR1, HDAC1 and RANGAP1. Interacts with AKT1, AKT2 and AKT3. Interacts (via TRAF domains) with NUMBL (via C-terminal). Interacts (via TRAF domains) with WDR34 (via WD domains). Interacts with RBCK1. Interacts with TRAF3IP2. Interacts with LIMD1 (via LIM domains). Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Belongs to the TNF receptor-associated factor family. A subfamily.

Protein type: Ligase; EC 6.3.2.-; Ubiquitin ligase; Ubiquitin conjugating system

Cellular Component: internal side of plasma membrane; protein complex; mitochondrion; perinuclear region of cytoplasm; cytoplasm; nucleolus; plasma membrane; lipid particle; intracellular; cell cortex; nucleus; cytosol

Molecular Function: protein kinase B binding; zinc ion binding; ubiquitin conjugating enzyme binding; ubiquitin protein ligase binding; histone deacetylase binding; thioesterase binding; ubiquitin-protein ligase activity; protein N-terminus binding; mitogen-activated protein kinase kinase kinase binding; protein kinase binding; tumor necrosis factor receptor binding; ligase activity

Biological Process: I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK activity; protein polyubiquitination; positive regulation of osteoclast differentiation; positive regulation of smooth muscle cell proliferation; positive regulation of interleukin-6 biosynthetic process; positive regulation of lipopolysaccharide-mediated signaling pathway; antigen processing and presentation of exogenous peptide antigen via MHC class II; protein ubiquitination; positive regulation of T cell cytokine production; myeloid dendritic cell differentiation; osteoclast differentiation; negative regulation of transcription from RNA polymerase II promoter; signal transduction; bone remodeling; T cell receptor signaling pathway; activation of NF-kappaB transcription factor; regulation of apoptosis; JNK cascade; protein complex assembly; positive regulation of T cell proliferation; regulation of immunoglobulin secretion; bone resorption; protein autoubiquitination; T-helper 1 type immune response; ossification; positive regulation of I-kappaB kinase/NF-kappaB cascade; cytokine and chemokine mediated signaling pathway; activation of NF-kappaB-inducing kinase; odontogenesis of dentine-containing teeth; organ morphogenesis; positive regulation of interleukin-12 biosynthetic process; neural tube closure; activation of protein kinase activity; positive regulation of interleukin-2 production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription factor activity; immune response; negative regulation of transcription, DNA-dependent; cell development